- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 4GA: 1-butyl-3-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-3-ium(Covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 2 residues within 4Å:- Chain A: D.238
- Ligands: 4GA.1
4 PLIP interactions:1 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.238, H2O.1, H2O.1, H2O.1
MG.3: 5 residues within 4Å:- Chain A: D.98, D.102, Q.166
- Ligands: 4GA.1, MG.4
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.98, A:D.102, H2O.1, H2O.1
MG.4: 5 residues within 4Å:- Chain A: D.98, D.102, R.107
- Ligands: 4GA.1, MG.3
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.98, A:D.102, H2O.1, H2O.1
MG.8: 2 residues within 4Å:- Chain B: D.238
- Ligands: 4GA.7
4 PLIP interactions:1 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:D.238, H2O.3, H2O.3, H2O.3
MG.9: 5 residues within 4Å:- Chain B: D.98, D.102, Q.166
- Ligands: 4GA.7, MG.10
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.98, B:D.102, H2O.3, H2O.3
MG.10: 5 residues within 4Å:- Chain B: D.98, D.102, R.107
- Ligands: 4GA.7, MG.9
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.98, B:D.102, H2O.3, H2O.3
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.5: 9 residues within 4Å:- Chain A: R.55, Q.91, R.107, F.234, D.238, K.252, R.346
- Ligands: 4GA.1, PO4.6
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:Q.91, A:R.107, A:R.346
- Water bridges: A:D.238
- Salt bridges: A:K.52, A:R.55, A:K.252
PO4.6: 6 residues within 4Å:- Chain A: G.51, K.52, R.55, Q.91, R.108
- Ligands: PO4.5
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:K.52, A:Q.91
- Water bridges: A:Y.53, A:R.55, A:K.348
- Salt bridges: A:K.52, A:R.55, A:R.108
PO4.11: 9 residues within 4Å:- Chain B: R.55, Q.91, R.107, F.234, D.238, K.252, R.346
- Ligands: 4GA.7, PO4.12
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:Q.91, B:R.107, B:D.238, B:R.346
- Water bridges: B:D.238
- Salt bridges: B:K.52, B:R.55, B:K.252
PO4.12: 6 residues within 4Å:- Chain B: G.51, K.52, R.55, Q.91, R.108
- Ligands: PO4.11
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:K.52, B:Q.91
- Water bridges: B:Y.53, B:R.55, B:K.348
- Salt bridges: B:K.52, B:R.55, B:R.108
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis. ACS MED.CHEM.LETT. (2013)
- Release Date
- 2013-05-08
- Peptides
- Farnesyl pyrophosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 4GA: 1-butyl-3-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-3-ium(Covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis. ACS MED.CHEM.LETT. (2013)
- Release Date
- 2013-05-08
- Peptides
- Farnesyl pyrophosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A